Yıl: 2014 Cilt: 15 Sayı: 3 Sayfa Aralığı: 106 - 111 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

Toll-Like Receptor 2 Expression and Peripheral Blood CD4+/CD8+ T Cell Ratio in COPD

Öz:
as well as the relationship of these cells with pulmonary functions in chronic obstructive pulmonary disease (COPD) patients.MATerIAL ANd MeTHods: Forty COPD patients and 40 healthy volunteers were included. Participants were analysed in four groups according to their smoking status. Peripheral blood CD4+ and CD8+ T cells and monocyte TLR-2 expression were measured by flow cytometry in the whole study population.resULTs: No significant difference was observed in TLR-2 expression, number of CD4+ and CD8+ T cells, and CD4+/CD8+ T cell ratio between the study groups. CD4+/CD8+ T cell ratio and FEV1/FVC were found to have a mild positive correlation (r=0.295, p=0.022). A mild negative correlation was observed between smoking intensity and CD4+/CD8+ T cell ratio (r=-0.274, p=0.034).CoNCLUsIoN: We demonstrated a mild correlation between pulmonary functions and peripheral blood CD4+/CD8+ T cell ratio. However, we did not find a significant difference in TLR-2 expression of CD14+ monocytes in patients with airway obstruction.
Anahtar Kelime:

Konular: Solunum Sistemi Kulak, Burun, Boğaz
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • Global Strategy of Diagnosis, Management and Prevention of COPD, 2006. www.goldcopd.com. Date last updated: Decem- ber 2009. Date last accessed: May 2010.
  • Sarir H, Henricks PA, van Houwelingen AH, et al. Cells, me- diators and Toll-like receptors in COPD. Eur J Pharmacol 2008;585:346-53. [Crossref]
  • Medzhitov R, Janeway Jr C. Innate immunity. N Engl J Med 2000;343:338-44. [Crossref]
  • Finkelstein R, Fraser RS, Ghezzo H, Cosio MG. Alveolar inflam- mation and its relation to emphysema in smokers. Am J Respir Crit Care Med 1995;152:1666-72. [Crossref]
  • Sarir H, Mortaz E, Karimi K, et al. Cigarette smoke regulates the expression of TLR-4 and IL-8 production by human macro- phages. J Inflamm (Lond) 2009;6:12. [Crossref]
  • Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human ho- mologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997;388:394-7. [Crossref]
  • Chaudhuri N, Dower SK, Whyte MKB, Sabroe I. Toll-like receptors and chronic lung disease. Clin Sci 2005;109:125-33. [Crossref]
  • Akbulut H. Toll-Like Receptors. Turkiye Klinikleri J Int Med Sci 2007;3:14-7.
  • Texereau J, Chiche JD, Taylor W, et al. The importance of Toll- like receptor 2 polymorphisms in severe infections. Clin Infect Dis 2005; 41:408-15. [Crossref]
  • Droemann D, Goldmann T, Branscheid D, et al. Toll-like receptor 2 is expressed by alveolar epithelial cells type II and macrophages in the human lung. Histochem Cell Biol 2003;119:103-8.
  • Armstrong L, Medford AR, Uppington KM, et al. Expression of functional toll-like receptor-2 and -4 on alveolar epithelial cells. Am J Respir Cell Mol Biol 2004;31:241-5. [Crossref]
  • Andonegui G, Bonder CS, Green F, et al. Endothelium-derived Toll-like receptor-4 is the key molecule in LPS-induced neu- trophil sequestration into lungs. J Clin Invest 2003;111:1011- 20. [Crossref]
  • Geraghty P, Dabo AJ, D'Armiento J. TLR-4 contributes to ciga- rette smoke (CS) induced matrix metalloproteinase-1 (MMP-1) expression in chronic obstructive pulmonary disease. J Biol Chem 2011;286:30211-8. [Crossref]
  • Droemann D, Goldmann T, Tiedje T, et al. Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients. Respir Res 2005;6:68. [Crossref]
  • Folds JD. Overview of Immunity. In: O'Gorman MRG, Donnen- berg AD, eds. Handbook of human immunology, 2nd ed. New York: CRC Pres, 2008:18-23. [Crossref]
  • Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;24:2645-53. [Crossref]
  • O'Shaughnessy TC, Ansari TW, Barnes NC, Jeffery PK. Inflam- mation in bronchial biopsies of subjects with chronic bronchi- tis: inverse relationship of CD8+ T lymphocytes with FEV1. Am J Respir Crit Care Med 1997;155:852-7. [Crossref]
  • Kim WD, Kim WS, Koh Y, et al. Abnormal peripheral blood T- lymphocyte subsets in a subgroup of patients with COPD. Chest 2002;122:437-44. [Crossref]
  • Lewis SA, Pavord ID, Stringer JR, et al. The relation between peripheral blood leukocyte counts and respiratory symptoms, atopy, lung function, and airway responsiveness in adults. Chest 2001;119:105-14. [Crossref]
  • American Thoracic Society Statement. Lung function testing: se- lection of reference values and interpretative strategies. Am Rev Respir Dis 1991;144:1202-18. [Crossref]
  • Lafferty EI, Qureshi ST, Schnare M. The role of toll-like recep- tors in acute and chronic lung inflammation. J Inflamm (Lond) 2010;7:57. [Crossref]
  • Arancibia SA, Beltrán CJ, Aguirre IM, et al. Toll-like Recep- tors are key participants in innate immune responses. Biol Res 2007;40:97-112. [Crossref]
  • Zhu YK, Liu X, Wang H, et al. Interactions between monocytes and smooth-muscle cells can lead to extracellular matrix degra- dation. J Allergy Clin Immunol 2001;108:989-96. [Crossref]
  • Morris GE, Whyte MK, Martin GF, et al. Agonists of Toll-like receptors 2 and 4 activate airway smooth muscle via mononu- clear leukocytes. Am J Respir Crit Care Med 2005;171:814-22. [Crossref]
  • Hayashi F, Means TK, Luster AD. Toll-like receptors stimulate hu- man neutrophil function. Blood 2003;102;2660-9. [Crossref]
  • Sabroe I, Prince LR, Jones EC, et al. Selective roles for Toll-like receptor (TLR)2 and TLR4 in the regulation of neutrophil activa- tion and life span. J Immunol 2003;170:5268-75. [Crossref]
  • Basu S, Fenton MJ. Toll-like receptors: function and roles in lung disease. Am J Physiol Lung Cell Mol Physiol 2004;286:887-92. [Crossref]
  • Hybiske K, Ichikawa JK, Huang V, et al. Cystic fibrosis airway epithelial cell polarity and bacterial flagellin determine host re- sponse to Pseudomonas aeruginosa. Cell Microbiol 2004;6:49-63. [Crossref]
  • Petit-Bertron AF, Tabary O, Corvol H, et al. Circulating and air- way neutrophils in cystic fibrosis display different TLR expression and responsiveness to interleukin-10. Cytokine 2008;41:54-60. [Crossref]
  • Droemann D, GoldmannT, Tiedje T, et al. Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients. Respir Res 2005;6:68. [Crossref]
  • Pons AR, Sauleda J, Noguera A, et al. Decreased macrophage release of TGF-beta and TIMP-1 in chronic obstructive pulmo- nary disease. Eur Respir J 2005;26:60-6. [Crossref]
  • Pan MM, Sun TY, Zhang HS. Expression of toll-like receptors on CD14+ monocytes from patients with chronic obstructive pulmonary disease and smokers. Zhonghua Yi Xue Za Zhi 2008;88:2103-7.
  • Pons J, Sauleda J, Regueiro V, et al. Expression of Toll-like receptor 2 is up-regulated in monocytes from patients with chronic obstruc- tive pulmonary disease. Respir Res 2006;7:64. [Crossref]
  • Nadigel J, Préfontaine D, Baglole CJ, et al. Cigarette smoke in- creases TLR4 and TLR9 expression and induces cytokine pro- duction from CD8(+) T cells in chronic obstructive pulmonary disease. Respir Res 2011;9:149. [Crossref]
  • Hogg JC. Pathophysiology of airflow limitation in chronic obstruc- tive pulmonary disease. Lancet 2004;364:709-21. [Crossref]
  • Ginns LC, Goldenheim PD, Miller LG, et al. T-lymphocyte sub- sets in smoking and lung cancer: analysis by monoclonal anti- bodies and flow cytometry. Am Rev Respir Dis 1982;126:265-9.
  • de Jong JW, van der Belt-Gritter B, Koëter GH, Postma DS. Pe- ripheral blood lymphocyte cell subsets in subjects with chronic obstructive pulmonary disease: association with smoking, IgE and lung function. Respir Med 1997;91:67-76. [Crossref]
  • Glader P, Wachenfeldt K, Löfdahl CG. Systemic CD4+ T-cell activation is correlated with FEV1 in smokers. Respir Med 2006;100:1088-93. [Crossref]
  • Domagala-Kulawik J, Hoser G, Dabrowska M, Chazan R. In- creased proportion of Fas positive CD8+ cells in peripheral blood of patients with COPD. Respir Med 2007;101:1338-43. [Crossref]
  • Rufino R, Costa CH, Souza HS, et al. Induced sputum and pe- ripheral blood cell profile in chronic obstructive pulmonary dis- ease. J Bras Pneumol 2007;33:510-8.
APA ULUTAŞ G, ÖZGEN ALPAYDIN A, TANELİ F, ÇETİNKAYA C, Ulman C, GÜVENÇ DEMİRAĞCI Y, DİNÇ HORASAN G, ŞAKAR COŞKUN A (2014). Toll-Like Receptor 2 Expression and Peripheral Blood CD4+/CD8+ T Cell Ratio in COPD. , 106 - 111.
Chicago ULUTAŞ Gürol Şahin,ÖZGEN ALPAYDIN Aylin,TANELİ FATMA,ÇETİNKAYA Cemile,Ulman Cevval,GÜVENÇ DEMİRAĞCI YEŞİM,DİNÇ HORASAN Gönül,ŞAKAR COŞKUN AYŞIN Toll-Like Receptor 2 Expression and Peripheral Blood CD4+/CD8+ T Cell Ratio in COPD. (2014): 106 - 111.
MLA ULUTAŞ Gürol Şahin,ÖZGEN ALPAYDIN Aylin,TANELİ FATMA,ÇETİNKAYA Cemile,Ulman Cevval,GÜVENÇ DEMİRAĞCI YEŞİM,DİNÇ HORASAN Gönül,ŞAKAR COŞKUN AYŞIN Toll-Like Receptor 2 Expression and Peripheral Blood CD4+/CD8+ T Cell Ratio in COPD. , 2014, ss.106 - 111.
AMA ULUTAŞ G,ÖZGEN ALPAYDIN A,TANELİ F,ÇETİNKAYA C,Ulman C,GÜVENÇ DEMİRAĞCI Y,DİNÇ HORASAN G,ŞAKAR COŞKUN A Toll-Like Receptor 2 Expression and Peripheral Blood CD4+/CD8+ T Cell Ratio in COPD. . 2014; 106 - 111.
Vancouver ULUTAŞ G,ÖZGEN ALPAYDIN A,TANELİ F,ÇETİNKAYA C,Ulman C,GÜVENÇ DEMİRAĞCI Y,DİNÇ HORASAN G,ŞAKAR COŞKUN A Toll-Like Receptor 2 Expression and Peripheral Blood CD4+/CD8+ T Cell Ratio in COPD. . 2014; 106 - 111.
IEEE ULUTAŞ G,ÖZGEN ALPAYDIN A,TANELİ F,ÇETİNKAYA C,Ulman C,GÜVENÇ DEMİRAĞCI Y,DİNÇ HORASAN G,ŞAKAR COŞKUN A "Toll-Like Receptor 2 Expression and Peripheral Blood CD4+/CD8+ T Cell Ratio in COPD." , ss.106 - 111, 2014.
ISNAD ULUTAŞ, Gürol Şahin vd. "Toll-Like Receptor 2 Expression and Peripheral Blood CD4+/CD8+ T Cell Ratio in COPD". (2014), 106-111.
APA ULUTAŞ G, ÖZGEN ALPAYDIN A, TANELİ F, ÇETİNKAYA C, Ulman C, GÜVENÇ DEMİRAĞCI Y, DİNÇ HORASAN G, ŞAKAR COŞKUN A (2014). Toll-Like Receptor 2 Expression and Peripheral Blood CD4+/CD8+ T Cell Ratio in COPD. Türk Toraks Dergisi, 15(3), 106 - 111.
Chicago ULUTAŞ Gürol Şahin,ÖZGEN ALPAYDIN Aylin,TANELİ FATMA,ÇETİNKAYA Cemile,Ulman Cevval,GÜVENÇ DEMİRAĞCI YEŞİM,DİNÇ HORASAN Gönül,ŞAKAR COŞKUN AYŞIN Toll-Like Receptor 2 Expression and Peripheral Blood CD4+/CD8+ T Cell Ratio in COPD. Türk Toraks Dergisi 15, no.3 (2014): 106 - 111.
MLA ULUTAŞ Gürol Şahin,ÖZGEN ALPAYDIN Aylin,TANELİ FATMA,ÇETİNKAYA Cemile,Ulman Cevval,GÜVENÇ DEMİRAĞCI YEŞİM,DİNÇ HORASAN Gönül,ŞAKAR COŞKUN AYŞIN Toll-Like Receptor 2 Expression and Peripheral Blood CD4+/CD8+ T Cell Ratio in COPD. Türk Toraks Dergisi, vol.15, no.3, 2014, ss.106 - 111.
AMA ULUTAŞ G,ÖZGEN ALPAYDIN A,TANELİ F,ÇETİNKAYA C,Ulman C,GÜVENÇ DEMİRAĞCI Y,DİNÇ HORASAN G,ŞAKAR COŞKUN A Toll-Like Receptor 2 Expression and Peripheral Blood CD4+/CD8+ T Cell Ratio in COPD. Türk Toraks Dergisi. 2014; 15(3): 106 - 111.
Vancouver ULUTAŞ G,ÖZGEN ALPAYDIN A,TANELİ F,ÇETİNKAYA C,Ulman C,GÜVENÇ DEMİRAĞCI Y,DİNÇ HORASAN G,ŞAKAR COŞKUN A Toll-Like Receptor 2 Expression and Peripheral Blood CD4+/CD8+ T Cell Ratio in COPD. Türk Toraks Dergisi. 2014; 15(3): 106 - 111.
IEEE ULUTAŞ G,ÖZGEN ALPAYDIN A,TANELİ F,ÇETİNKAYA C,Ulman C,GÜVENÇ DEMİRAĞCI Y,DİNÇ HORASAN G,ŞAKAR COŞKUN A "Toll-Like Receptor 2 Expression and Peripheral Blood CD4+/CD8+ T Cell Ratio in COPD." Türk Toraks Dergisi, 15, ss.106 - 111, 2014.
ISNAD ULUTAŞ, Gürol Şahin vd. "Toll-Like Receptor 2 Expression and Peripheral Blood CD4+/CD8+ T Cell Ratio in COPD". Türk Toraks Dergisi 15/3 (2014), 106-111.